We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Curon Medical, a developer, manufacturer and marketer of radiofrequency generators
and single use disposable devices, announced that on Dec. 22 the Nasdaq Listing
Qualifications Department notified the company that as a result of Alan Kaganov's
Dec. 1 resignation from the board of directors, the corporation was no longer
in compliance with Nasdaq's audit committee composition requirement because
it did not have the requisite number of directors serving on its audit committee.
Los Angeles, Calif.-based Diagnostic Products promoted Sidney Aroesty, the company's
senior vice president of operations and chief operating officer, to the additional
post of president.
Windsor, Conn.-based Scapa Medical has announced Bioflex Rx232V-60, a single
coated medical grade polyethylene foam adhesive for use in medical device assembly
or direct skin contact applications.
SonoSite has announced it began customer shipments of the SonoCalc IMT software,
allowing physicians to quickly and effectively measure the wall thickness (IMT)
of the common carotid arteries and assess a patient's risk of cardiovascular
disease.
The Purdue Research Foundation partnered with Memphis, Tenn.-based Medtronic
Sofamor Danek to commercialize technology discovered at Purdue University that
may someday prevent paralysis in humans with spinal cord injuries.
Alfresa Holdings has announced its subsidiary Alfresa Pharma launched the Hemotect
NS-Plus C, an automated immunochemical analyzer, and its proprietary reagent
Nescoat HemoPlus for fecal occult blood tests.
ForHealth Technologies has successfully completed
the transition for the manufacture of its flagship robotic technology IntelliFill
i.v. from a California-based contract manufacturer to Delphi Medical Systems.
IntelliFill i.v. automates the compounding and labeling of intravenous doses
in syringes at speeds that can only be achieved through automated processes.
Xillix Technologies, a Canadian medical device company specializing in fluorescence
endoscopy for improved cancer detection, has closed a private placement of $5
million of convertible, unsecured debentures of Xillix Ltd., a wholly owned
Toronto-based subsidiary of the company.